Pacira BioSciences, Inc. announced preliminary net product sales results for August 2022. For the month, the company's net product sales were $59.1 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.81 USD | +2.72% | -0.22% | -20.54% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.54% | 1.21B | |
+27.92% | 659B | |
+27.68% | 557B | |
-4.59% | 359B | |
+16.38% | 322B | |
+9.39% | 297B | |
+6.30% | 215B | |
+4.80% | 210B | |
-6.05% | 200B | |
-8.58% | 149B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Pacira BioSciences, Inc. Announces Preliminary Net Product Sales Results for August 2022